Navigation Links
Scottish medical charity and international drug consortium form partnership
Date:1/26/2012

Developing World Health (DWH), a leading medical charity based in Stirlingshire, Scotland and committed to developing effective treatments for neglected tropical diseases, has signed a collaboration agreement with the internationally respected Consortium for Parasitic Drug Development (CPDD), based at The University of North Carolina at Chapel Hill.

The collaboration agreement to develop new drugs is believed to be the first between a UK medical charity and international scientific consortium focused on neglected tropical diseases.

An estimated 16% of the world's population suffer from one or more neglected tropical diseases with 90% of cases recorded in Africa.

The agreement may prove highly lucrative, potentially generating in excess of $15 million investment in drug development for NTDs that urgently need safe and effective new treatments. Referring to the collaboration agreement with CPDD, Dr Stuart WG Smith, Founder and CEO of Scottish medical charity Developing World Health, commented: "Developing World Health's objective is to facilitate the development of new treatments for NTDs. This collaboration will mean that we can expedite the development of novel treatments and help save the lives of many more children and adults afflicted by the scourge of NTD's."

Dr Rick Tidwell, Director of the Consortium for Parasitic Drug Development (CPDD) based at the University of North Carolina at Chapel Hill, commented: "This is a very welcome and exciting strategic partnership and brings together additional expertise to increase funding and collaboration opportunities for the Consortium and enhance the rapid development of novel treatments for NTDs such as African sleeping sickness and leishmaniasis."

The partnership means DWH and CPDD can effectively source funding from commercial, government and not-for-profit organisations to develop and / or improve effective treatments for preventable, treatable diseases like leishmaniasis, African trypanosomiasis (sleeping sickness), Chagas disease (American trypanosomiasis) and Dengue.

The partnership enables the charity to bridge the 'missing link' between academics requiring research funding and the pharmaceutical industry interested in tackling these devastating tropical diseases.

The CPDD currently has in its portfolio, a novel compound shown to be 100% curative in models of late-stage stage African Trypanosomiasis ("sleeping sickness"). This disease is caused by microscopic parasites of the species Trypanosoma brucei and is transmitted by the tsetse fly found only in rural Africa. Currently, about 10,000 new cases each year are reported to the World Health Organization. However, it is believed that many cases go undiagnosed and unreported. Sleeping sickness is fatal if left untreated.

The CPDD brings together some of the world's top experts in drug development and delivery from UNC-Chapel Hill, Georgia State University, the University of Glasgow, Ohio State University, the Swiss Tropical Institute, and the Kenya Trypanosomiasis Research Institute among others.


'/>"/>

Contact: Colin Hutchison
chutchison@3x1.com
44-131-225-7700
University of North Carolina School of Medicine
Source:Eurekalert

Related medicine news :

1. Wild Scottish sheep could help explain differences in immunity
2. Heart disease study highlights Scottish ethnic groups most at risk
3. TheReliefPlace.com Launches Online Store “The Relief Shop” - What Does this Medical Supply Store Carry and How Can They Help You?
4. Medical Transcription Services and EHR Provider MxSecure Launches New Enhanced Website with Goal of Improved Physician Productivity
5. Medical Training School, Pima Medical Institute Offering First Bachelor's Degree Program
6. FDA Seeks Reduction in Radiation From Medical Scans
7. UH Case Medical Center researchers publish promising findings for advanced cervical cancer
8. University of Virginia Health System Medical Laboratories Selects Sunquest's Specimen Collection Solution
9. Medical Imaging Northwest Completes Phase I of Its Healthcare IT Integration to Maintain Patient Care Improvements
10. Centene Corporation Hosts Medical Management Systems Update in New York City
11. CelebrityDiagnosis.com Nominated as Best New Medical Blog of 2009
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... 2017 , ... Information about the technology: , Otomagnetics has ... prevention of a major side effect of chemotherapy in children. Cisplatin and carboplatin ... cisplatin, hearing loss is FDA listed on-label as a dose limiting toxicity. Hearing ...
(Date:10/12/2017)... ... October 12, 2017 , ... HMP , a leader in ... 2017 Folio Magazine Eddie Digital Award for ‘Best B-to-B Healthcare Website.’ Winners were announced ... 2017. , The annual award competition recognizes editorial and design excellence across a range ...
(Date:10/12/2017)... ... October 12, 2017 , ... On Saturday, October 21, the Health ... Miles by Moonlight to raise money for the American Heart Association Heart Walk. Teams ... Teams will work together to keep their treadmills moving for 5 hours. Treadmills will ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... first interactive health literacy software tool, and the Cancer Patient Education Network (CPEN), ... patient education, today announce a new strategic alliance. , As CPEN’s strategic ...
(Date:10/12/2017)... Miramar, FL (PRWEB) , ... October 12, 2017 ... ... is presenting the latest in wound care advancements to physician colleagues, skilled nursing ... lecture is titled, "Navigating the Treacherous Waters of Wound Care." , "At many ...
Breaking Medicine News(10 mins):
(Date:10/12/2017)... 12, 2017   Divoti USA will engrave ... the standard of the latest FDA requirements, which stipulates new criteria ... Anyone in need of Medical ID jewelry such as Medical ID ... are engraved in terms of the new FDA requirements . ... Divoti offers this dark mark ...
(Date:10/11/2017)... 2017  True Health, a leader in integrated ... during National Breast Cancer Awareness month to educate ... Research recently published ... more than 10 million American women are at ... or BRCA2 and have not had testing. These mutations ...
(Date:10/7/2017)... Oct. 6, 2017   Provista, a proven ... $100 billion in purchasing power, today announced a new ... The Newsroom is the online home for ... infographics, expert bios, news releases, slideshows and events. ... a wealth of resources at their fingertips, viewers can ...
Breaking Medicine Technology: